JNJ
JOHNSON & JOHNSON
NYSE · Healthcare · Drug Manufacturers - General · US
$253.96
−0.63%Forward multiples
Based on analyst estimates
- P/E forward
- 22.04x
- P/E 2026E
- 22.70x
- P/E 2027E
- 21.44x
- P/E 2028E
- 18.08x
- P/S forward
- 5.76x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.50x
- PEG TTM
- 0.51x
- Price / book
- —
- Price / sales
- 6.16x
- Price / cash flow
- 24.95x
Enterprise value
- Enterprise value
- —
- EV / sales
- —
- EV / EBITDA
- —
- EV / EBIT
- —
- Market cap
- $612.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026